Overview

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.

Phase:

Phase 3

Details

Lead Sponsor:

University Health Network, Toronto

Collaborator:

Canadian Institutes of Health Research (CIHR)

Treatments:

Lidocaine